纤维板层型肝细胞癌:治疗前动态增强CT的原发肿瘤特征及远处转移模式
研究33例经病理证实的纤维板层型肝细胞癌患者的治疗前动态增强CT,评估原发肿瘤征象及远处转移模式。结果显示多数为单发大肿块,动脉期不均匀富血供强化,延迟期多呈等密度;中央星状瘢痕伴钙化为有用诊断特征,肺为最常见远处转移部位。
要点
- 纤维板层型肝细胞癌典型表现为单发大肿块,动脉期不均匀富血供强化,延迟期多呈等密度。
- 中央星状瘢痕见于73%(24/33),其中88%(21/24)瘢痕内伴钙化,有助于诊断。
- 54%(18/33)出现远处转移,其中肺为最常见转移部位(89%,16/18)。
核心结论
- 纤维板层型肝细胞癌典型表现为单发大肿块,动脉期呈不均匀富血供强化,多数在延迟期呈等密度;中央星状瘢痕伴内部钙化是有助于诊断的影像特征,肺为最常见远处转移部位。
研究设计与样本
- 研究纳入33例经病理证实且治疗前接受动态增强CT的纤维板层型肝细胞癌患者,平均年龄28岁(17男/16女),由两名腹部放射科医师共识评估动态增强CT影像特征。
关键影像表现/征象
- 单发肝脏肿块见于67%(22/33),平均肿瘤大小11.3 cm(范围4.6–22 cm),边界清晰者占64%(21/33)。
- 平扫CT上91%(30/33)呈低密度;中央星状瘢痕见于73%(24/33),有中央星状瘢痕者中88%(21/24)瘢痕内可见钙化。
- 肝动脉期82%(27/33)呈相对于肝脏的高密度;门静脉期36%(12/33)呈高密度、46%(15/33)呈等密度、18%(6/33)呈低密度。
- 延迟期24%(8/23)呈高密度、67%(22/33)呈等密度、9%(3/33)呈低密度;中央星状瘢痕延迟强化见于12%(4/33)。
- 远处转移见于54%(18/33),最常见转移部位为肺,在有转移的患者中占89%(16/18)。
临床应用与阅片要点
- 在动脉期观察到单发大肿块呈不均匀富血供强化,且延迟期多呈等密度时,可提示纤维板层型肝细胞癌。
- 中央星状瘢痕伴内部钙化是有助于诊断纤维板层型肝细胞癌的影像特征。
- 诊断时需注意评估肺等远处转移,因肺为最常见远处转移部位。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of our study is to describe the multiphasic CT features of fibrolamellar hepatocellular carcinomas (FLHCCs) and pattern of distant metastases.
MATERIALS AND METHODS: 33 patients (mean age 28 years: 17M/16F) with pathologically confirmed FLHCC and pre-treatment multiphasic CT were included in the study. Two abdominal radiologists evaluated the multiphasic CT imaging features of these 33 FLHCC patients in consensus.
RESULTS: Solitary hepatic mass was seen in 67% (22/33). Mean tumor size was 11.3 cm (range 4.6-22 cm). Tumor was well-defined in 64% (21/33). In the pre-contrast CT, 91% (30/33) were hypoattenuating. Central stellate scar was present in 73% (24/33). In FLHCC having central stellate scar, calcification within the central scar was seen in 88% (21/24). In the hepatic arterial phase, 82% (27/33) were hyperattenuating relative to liver. In the portal venous phase, 36% (12/33) were hyperattenuating, 46% (15/33) were isoattenuating, and 18% (6/33) were hypoattenuating. In the delayed phase images, 24% (8/23) were hyperattenuating, 67% (22/33) were isoattenuating, and 9% (3/33) were hypoattenuating. Delayed enhancement of the central stellate scar was seen in 12% (4/33). Distant metastases were seen in 54% (18/33). The most common site of metastases was lungs and was seen in 89% (16/18) of the patients with metastatic disease.
CONCLUSION: FLHCC typically manifests as a large, solitary mass demonstrating heterogeneous hypervascular enhancement in the arterial phase. Most tend to be isoattenuating in delayed phase. Central stellate scar with internal calcification is a useful imaging feature that can help in the diagnosis of FLHCC. Lungs are the most common site of distant metastases in FLHCC.
引用
- Ganeshan D, Szklaruk J, Kaseb A, et al. Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases. Abdom Radiol (NY). 2018. PMID: 29948061. doi:10.1007/s00261-018-1657-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。